TW200732308A - Substituted 4-aminoquinazoline derivatives, preparation thereof and therapeutic application thereof - Google Patents
Substituted 4-aminoquinazoline derivatives, preparation thereof and therapeutic application thereofInfo
- Publication number
- TW200732308A TW200732308A TW095137552A TW95137552A TW200732308A TW 200732308 A TW200732308 A TW 200732308A TW 095137552 A TW095137552 A TW 095137552A TW 95137552 A TW95137552 A TW 95137552A TW 200732308 A TW200732308 A TW 200732308A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkylene
- alkyl
- aryl
- optionally substituted
- nrarb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
The invention relates to 4-aminoquinazoline derivatives of general formula (I), in which: A, B = optionally substituted C1-4-alkylene; L = single bond, C1-2-alkylene, -CH=CH- or -C≡C-; the groups C1-2-alkylene and -CH=CH- being optionally substituted, or L = cyctoprop-1,2-diyl;R = H, C1-5-alkyl, C1-3-fluoroalkyl, C3-6-cydoalkyl, - C(O)C1-3-alkyl, C1-3-alkylene-C3-6-cycloalkyl, -CH2-C≡CH, C2-4-alkylene-NRaRb or C1-3-alkylene-X-C1-3-alkyl in which X = O, SO2; R1 = aryl or heteroaryl; optionally substituted; R2 and R3 = H, C1-3-alkyl or C1-3-fluoroalkyl, or alternatively R2 and R3 together form a cycloprop-1,1-diyl; R4 = H, C1-5-alkyl, C1-3-fluoroalkyl, C1-5-alkoxy, -SF5, C1-3-alkylene-X-C1-3-alkyl in which X = O or SO2, C1-5-alkylene-NRaRb, an aryl or a heteroaryl, which are optionally substituted; R5 = H, halogen, C1-5-alkyl, C1-3-fluoroalkyl, C1-5-alkoxy, C3-6-cycloalkyl, C1-3-alkylene-C3-6-cycloalkyl, C1-3-alkylene-O-C1-3-alkyl, C1-3-alkylene-(OH) or C1-3-alkylene-X-C1-3-alkyl in which X = S, SO or SO2, or alternatively R5 = -NRaRb, C1-3-alkylene-NRaRb, aryl, C1-3-alkylene-aryl, -O-aryl, C1-3-alkylene-O-aryl, C1-3-alkylene-O-C1-3-alkylene-aryl, heteroaryl or C1-3-alkylene-heteroaryl, which are optionally substituted, or R5 = heterocycle optionally substituted with C1-3-alkyl, -C(O)C1-3-alkyl, -C(O)C1-3-fluoroalkyl, C1-3-alkylene-C3-6-cycloalkyl, C1-3-alkylene-aryl, C1-3-alkylene-heteroaryl, which are optionally substituted; R7 = H, halogen, C1-5-alkyl, C1-3-fluoroalkyl, C1-5-alkoxy, -COOH, -C(O)O-C1-3-alkyl, C1-3-fluoroalkoxy, C1-3-alkylene-(OH), -NO2, -CN or -X-C1-3-alkyl in which X represents S, SO or SO2, or alternatively R7 = -NRaRb, C1-3-alkylene-NRaRb, -C(O)-NRaRb, -C(o)-C1-3-alkyl, aryl, -O-aryl or heteroaryl, which are optionally substituted; in the form of base or of acid-addition salt, and also in the form of hydrate or solvate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0510409A FR2891829A1 (en) | 2005-10-12 | 2005-10-12 | 4-AMINO-QUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200732308A true TW200732308A (en) | 2007-09-01 |
Family
ID=36645639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095137552A TW200732308A (en) | 2005-10-12 | 2006-10-12 | Substituted 4-aminoquinazoline derivatives, preparation thereof and therapeutic application thereof |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR056688A1 (en) |
FR (1) | FR2891829A1 (en) |
TW (1) | TW200732308A (en) |
UY (1) | UY29857A1 (en) |
WO (1) | WO2007042669A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2009108280A (en) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Arylamino-arylalkyl-substituted imidazolidine-2,4-dione, methods for their preparation containing these compounds and their use |
AU2009249246A1 (en) | 2008-05-22 | 2009-11-26 | Allergan, Inc. | Bicyclic compounds having activity at the CXCR4 receptor |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
EP2683704B1 (en) | 2011-03-08 | 2014-12-17 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683699B1 (en) | 2011-03-08 | 2015-06-24 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
EP3302057A4 (en) * | 2015-06-04 | 2018-11-21 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
BR112018068702A2 (en) | 2016-03-16 | 2019-01-15 | Kura Oncology Inc | menin-mll bridged bicyclic inhibitors and methods of use |
EP3429591B1 (en) | 2016-03-16 | 2023-03-15 | Kura Oncology, Inc. | Substituted thieno[2,3-d]pyrimidine derivatives as inhibitors of menin-mll and methods of use |
WO2018175746A1 (en) | 2017-03-24 | 2018-09-27 | Kura Oncology, Inc. | Methods for treating hematological malignancies and ewing's sarcoma |
WO2018226976A1 (en) | 2017-06-08 | 2018-12-13 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
TW201920170A (en) | 2017-09-20 | 2019-06-01 | 美商庫拉腫瘤技術股份有限公司 | Substituted inhibitors of MENIN-MLL and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0126087A1 (en) * | 1982-09-24 | 1984-11-28 | Beecham Group Plc | Amino-azabicycloalkyl derivatives as dopamine antagonists |
GB2295387A (en) * | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
WO2003028641A2 (en) * | 2001-10-01 | 2003-04-10 | Taisho Pharmaceutical Co., Ltd. | Mch receptor antagonists |
EP1534703A2 (en) * | 2002-06-12 | 2005-06-01 | Abbott Laboratories | Antagonists of melanin concentrating hormone receptor |
WO2004052371A2 (en) * | 2002-12-11 | 2004-06-24 | 7Tm Pharma A/S | Cyclic quinoline compounds for use in mch receptor related disorders |
CL2004000409A1 (en) * | 2003-03-03 | 2005-01-07 | Vertex Pharma | COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU |
KR20060079121A (en) * | 2004-12-31 | 2006-07-05 | 에스케이케미칼주식회사 | Quinazoline derivatives for the treatment or prevention of diabetes and obesity |
-
2005
- 2005-10-12 FR FR0510409A patent/FR2891829A1/en not_active Withdrawn
-
2006
- 2006-10-11 AR ARP060104457A patent/AR056688A1/en not_active Application Discontinuation
- 2006-10-11 WO PCT/FR2006/002286 patent/WO2007042669A2/en active Application Filing
- 2006-10-12 TW TW095137552A patent/TW200732308A/en unknown
- 2006-10-12 UY UY29857A patent/UY29857A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
UY29857A1 (en) | 2007-05-31 |
AR056688A1 (en) | 2007-10-17 |
WO2007042669A2 (en) | 2007-04-19 |
WO2007042669A3 (en) | 2007-05-31 |
FR2891829A1 (en) | 2007-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200732308A (en) | Substituted 4-aminoquinazoline derivatives, preparation thereof and therapeutic application thereof | |
EA200970149A1 (en) | DERIVATIVES N- (AMINOHETEROARIL) -1H-INDOL-2-CARBOXAMIDES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY | |
TW200716654A (en) | Sulfoximine-macrocycle compounds and salts thereof, pharmaceutical compositions comprising said compounds, methods of preparing same and uses of same | |
TW200722079A (en) | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | |
UA95976C2 (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-b]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
TW200714589A (en) | Phenylacetamides suitable as protein kinase inhibitors | |
TW200621721A (en) | Methods of preparing indazole compounds | |
TW200833690A (en) | 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same | |
MX2010003495A (en) | Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof. | |
TW200612948A (en) | 2-substituted heteroaryl compounds | |
UA101819C2 (en) | Herbicidal 1h-2-thia-1,5,8-triazanaphthalene-2,2-dioxides | |
EA200801998A1 (en) | ПИРДДИН [3,4-b] ПИРАЗИНОНЫ | |
CY1113676T1 (en) | Substituted Beta-Finyl-Alpha-Hydroxy Propionic Acid, Method of Composition and Its Use | |
EA200700901A1 (en) | DERIVATIVES 2-AMIDO-4-PHENYL THIAZOLE, THEIR OBTAINING AND USE IN THERAPY | |
SE0401762D0 (en) | Novel compounds | |
CY1108366T1 (en) | 7- (2- (4- (3-Trifluoromethyl-phenyl-1,2,3,6-tetrahydro-pyrid-1-yl) ethyl) benzosulfonate salt of isokinoline, isoform | |
JO2682B1 (en) | 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof | |
TW200637817A (en) | 5-aminoindole derivatives | |
UY29859A1 (en) | DERIVATIVES OF 1-AMINO-ISIQUINOLINE, ITS PREPARATION AND THERAPEUTIC APPLICATION | |
MX2007007027A (en) | Piperazinyl pyridine derivatives as anti-obesity agents. | |
DE602007001463D1 (en) | PYRIMIDINE, CHINAZOLIN, PTERIDINE AND TRIAZINE DERIVATIVES | |
EA201070281A1 (en) | INDOL-2-ONE DERIVATIVES, DOUBLE SUBSTITUTES IN POSITION 3, THEIR RECEIVING AND THEIR USE IN THERAPY | |
DE602005016282D1 (en) | PROCESS FOR THE PREPARATION OF CAMPTOTHECIN DERIVATIVES | |
EA201100696A1 (en) | 1- (ARILSULPHONIL) -4- (PIPERAZIN-1-IL) -1H-BENZIMIDAZOLES AS 5-HYDROXITRIPTAMINE-6 LIGANDS | |
MX2009000768A (en) | Macrocyclic lactams. |